LEV PHARMACEUTICALS INC Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other May 5 Calls Today's Calls

Call Details LEV PHARMACEUTICALS INC Earnings Conference Call (Q1 2008) Mon, May 5, 2008, 8:30 am Eastern Listen to the archived event audio About LEV PHARMACEUTICALS INC (OTC BB:LEVP.OB) Lev Pharmaceuticals, Inc., a development stage biopharmaceutical company, develops and commercializes therapeutic products for the treatment of inflammatory diseases primarily in the United States. It develops C1-esterase inhibitor (C1-INH), a Phase III clinical trial product for the acute and prophylactic treatment of hereditary angioedema, which is a genetic disorder characterized by episodic attacks of edema in the extremities, face, abdomen, and airway passages. Lev Pharmaceuticals’ product is also used for the treatment of acute myocardial infarction or heart attack, and other diseases and disorders. Lev Pharmaceuticals is based in New York, New York. More Info: Quote | Chart | Profile | Reports | Research | Insider | Financials | Analyst Ratings